Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer's Disease.

Kassaar O, Pereira Morais M, Xu S, Adam EL, Chamberlain RC, Jenkins B, James TD, Francis PT, Ward S, Williams RJ, van den Elsen J.

Sci Rep. 2017 Feb 23;7:42874. doi: 10.1038/srep42874. Erratum in: Sci Rep. 2017 Apr 05;7:45417.

2.

Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.

Oikonomidi A, Tautvydaitė D, Gholamrezaee MM, Henry H, Bacher M, Popp J.

J Alzheimers Dis. 2017;60(1):273-281. doi: 10.3233/JAD-170335.

PMID:
28826184
3.

Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.

Popp J, Bacher M, Kölsch H, Noelker C, Deuster O, Dodel R, Jessen F.

J Psychiatr Res. 2009 May;43(8):749-53. doi: 10.1016/j.jpsychires.2008.10.006. Epub 2008 Nov 26.

PMID:
19038405
4.

Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease.

Li SQ, Yu Y, Han JZ, Wang D, Liu J, Qian F, Fan GH, Bucala R, Ye RD.

J Neuroinflammation. 2015 Sep 17;12:177. doi: 10.1186/s12974-015-0396-3.

5.

The role of macrophage migration inhibitory factor in Alzheimer's disease.

Bacher M, Deuster O, Aljabari B, Egensperger R, Neff F, Jessen F, Popp J, Noelker C, Reese JP, Al-Abed Y, Dodel R.

Mol Med. 2010 Mar;16(3-4):116-21. doi: 10.2119/molmed.2009.00123. Epub 2010 Feb 28.

6.

Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor.

Sun H, Zhang X, Zhao L, Zhen X, Huang S, Wang S, He H, Liu Z, Xu N, Yang F, Qu Z, Ma Z, Zhang C, Zhang Y, Hu Q.

J Cell Mol Med. 2015 Apr;19(4):836-49. doi: 10.1111/jcmm.12521. Epub 2015 Feb 8.

7.

Polymorphisms of the macrophage inhibitory factor and C-reactive protein genes in subjects with Alzheimer's dementia.

Flex A, Pola R, Serricchio M, Gaetani E, Proia AS, Di Giorgio A, Papaleo P, Bernabei R, Pola P.

Dement Geriatr Cogn Disord. 2004;18(3-4):261-4. Epub 2004 Jul 29.

PMID:
15286457
8.

Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts.

Münch G, Schinzel R, Loske C, Wong A, Durany N, Li JJ, Vlassara H, Smith MA, Perry G, Riederer P.

J Neural Transm (Vienna). 1998;105(4-5):439-61. Review.

PMID:
9720973
9.

Glycation vs. glycosylation: a tale of two different chemistries and biology in Alzheimer's disease.

Taniguchi N, Takahashi M, Kizuka Y, Kitazume S, Shuvaev VV, Ookawara T, Furuta A.

Glycoconj J. 2016 Aug;33(4):487-97. doi: 10.1007/s10719-016-9690-2. Epub 2016 Jun 21. Review.

PMID:
27325408
11.

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.

Chen Z, Zhong C.

Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Epub 2013 Jul 11. Review.

12.

Amyloid-β metabolite sensing: biochemical linking of glycation modification and misfolding.

Fawver JN, Schall HE, Petrofes Chapa RD, Zhu X, Murray IV.

J Alzheimers Dis. 2012;30(1):63-73. doi: 10.3233/JAD-2012-112114.

PMID:
22406446
13.

The critical role of macrophage migration inhibitory factor in insulin activity.

Vujicic M, Senerovic L, Nikolic I, Saksida T, Stosic-Grujicic S, Stojanovic I.

Cytokine. 2014 Sep;69(1):39-46. doi: 10.1016/j.cyto.2014.05.013. Epub 2014 Jun 4.

PMID:
25022960
14.

Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease.

Arab L, Sadeghi R, Walker DG, Lue LF, Sabbagh MN.

Curr Neuropharmacol. 2011 Dec;9(4):693-705. doi: 10.2174/157015911798376334.

15.

The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction.

Rosengren E, Bucala R, Aman P, Jacobsson L, Odh G, Metz CN, Rorsman H.

Mol Med. 1996 Jan;2(1):143-9.

16.

Regulation of macrophage migration inhibitory factor (MIF) expression by glucose and insulin in adipocytes in vitro.

Sakaue S, Nishihira J, Hirokawa J, Yoshimura H, Honda T, Aoki K, Tagami S, Kawakami Y.

Mol Med. 1999 Jun;5(6):361-71.

17.

Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid-induced apoptosis.

Saksida T, Stosic-Grujicic S, Timotijevic G, Sandler S, Stojanovic I.

Immunol Cell Biol. 2012 Aug;90(7):688-98. doi: 10.1038/icb.2011.89. Epub 2011 Nov 8.

PMID:
22064706
18.

Ubiquitous production of macrophage migration inhibitory factor by human gastric and intestinal epithelium.

Maaser C, Eckmann L, Paesold G, Kim HS, Kagnoff MF.

Gastroenterology. 2002 Mar;122(3):667-80.

PMID:
11875000
19.

Macrophage migration inhibitory factor diminishes muscle glucose transport induced by insulin and AICAR in a muscle type-dependent manner.

Miyatake S, Manabe Y, Inagaki A, Furuichi Y, Takagi M, Taoka M, Isobe T, Hirota K, Fujii NL.

Biochem Biophys Res Commun. 2014 Feb 21;444(4):496-501. doi: 10.1016/j.bbrc.2014.01.089. Epub 2014 Jan 25.

PMID:
24472542
20.

Role of macrophage migration inhibitory factor (MIF) in the effects of oxidative stress on human retinal pigment epithelial cells.

Ko JA, Sotani Y, Ibrahim DG, Kiuchi Y.

Cell Biochem Funct. 2017 Oct;35(7):426-432. doi: 10.1002/cbf.3292. Epub 2017 Sep 14.

PMID:
28906008

Supplemental Content

Support Center